This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 22/9/1409    most recent 01.ATV.0000033818.21748.99v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rodríguez, C. Articles by Badimon, L. Search for Related Content PubMed PubMed Citation Articles by Rodríguez, C. Articles by Badimon, L. Related Collections Lipids Mechanism of atherosclerosis/growth factors Other Vascular biology Pathophysiology Gene regulation

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1409.)
© 2002 American Heart Association, Inc.

Vascular Biology

Low Density Lipoproteins Downregulate Lysyl Oxidase in Vascular Endothelial Cells and the Arterial Wall

Cristina Rodríguez; Berta Raposo; José Martínez-González; Laura Casaní; Lina Badimon

From the Instituto de Investigación Cardiovascular de Barcelona, CSIC-ICCC-Hospital de Sant Pau, Barcelona, Spain.

Correspondence to Prof Lina Badimon, Laboratori d’Investigació Cardiovascular, Hospital de la Santa Creu i Sant Pau, Avda. Sant Antoni Maria Claret 167, 08025 Barcelona, Spain. E-mail lbmucv{at}cid.csic.es

Objective— Hypercholesterolemia induces endothelial dysfunction, a hallmark of the atherosclerotic process, modulating the expression of key genes in vascular endothelial cells.

Methods and Results— By differential display analysis, we have studied the effect of high concentrations of native low density lipoprotein (LDL) on endothelial gene expression. mRNA levels of lysyl oxidase (LOX), an enzyme involved in collagen and elastin cross-linking, were downregulated by LDL treatment in endothelial cells in a dose- and time-dependent manner (80% of inhibition by 180 mg/dL LDL for 24 hours). This reduction of LOX expression was associated with a decrease in LOX activity (40% and 54% of inhibition after 24 and 48 hours of LDL treatment, respectively). LOX mRNA half-life was not modified by LDL, but transcriptional inhibition blocked the effect of LDL. Inhibition of LOX activity by either LDL or ß-aminopropionitrile, an inhibitor of LOX, increased endothelial permeability (192±0.19- and 3.37±0.74-fold, respectively). Interestingly, a reduction in LOX expression (3.5-fold) was observed in vivo in the vascular wall of hypercholesterolemic pigs.

Conclusions— These findings suggest that LDL downregulation of LOX could contribute to the endothelial dysfunction caused by hypercholesterolemia, thus contributing to atherosclerotic plaque formation.

Key Words: endothelial cells • low density lipoproteins • lysyl oxidase • vascular permeability • hypercholesterolemia

This article has been cited by other articles:

				C. Rodriguez, J. Martinez-Gonzalez, B. Raposo, J. F. Alcudia, A. Guadall, and L. Badimon Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases Cardiovasc Res, July 1, 2008; 79(1): 7 - 13. [Abstract] [Full Text] [PDF]

				S. Aydin, S. Signorelli, T. Lechleitner, M. Joannidis, C. Pleban, P. Perco, W. Pfaller, and P. Jennings Influence of microvascular endothelial cells on transcriptional regulation of proximal tubular epithelial cells Am J Physiol Cell Physiol, February 1, 2008; 294(2): C543 - C554. [Abstract] [Full Text] [PDF]

				C. Bouez, C. Reynaud, E. Noblesse, A. Thepot, C. Gleyzal, J. Kanitakis, E. Perrier, O. Damour, and P. Sommer The Lysyl Oxidase LOX Is Absent in Basal and Squamous Cell Carcinomas and Its Knockdown Induces an Invading Phenotype in a Skin Equivalent Model Clin. Cancer Res., March 1, 2006; 12(5): 1463 - 1469. [Abstract] [Full Text] [PDF]

				C. J. Sullivan, T. H. Teal, I. P. Luttrell, K. B. Tran, M. A. Peters, and H. Wessells Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats Physiol Genomics, October 17, 2005; 23(2): 192 - 205. [Abstract] [Full Text] [PDF]

				B. Schieffer, T. Selle, A. Hilfiker, D. Hilfiker-Kleiner, K. Grote, U. J.F. Tietge, C. Trautwein, M. Luchtefeld, C. Schmittkamp, S. Heeneman, et al. Impact of Interleukin-6 on Plaque Development and Morphology in Experimental Atherosclerosis Circulation, November 30, 2004; 110(22): 3493 - 3500. [Abstract] [Full Text] [PDF]

				A. Krettek, G. K. Sukhova, and P. Libby Elastogenesis in Human Arterial Disease: A Role for Macrophages in Disordered Elastin Synthesis Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 582 - 587. [Abstract] [Full Text] [PDF]

				C. Rodriguez, B. Raposo, J. Martinez-Gonzalez, V. Llorente-Cortes, G. Vilahur, and L. Badimon Modulation of ERG25 expression by LDL in vascular cells Cardiovasc Res, April 1, 2003; 58(1): 178 - 185. [Abstract] [Full Text] [PDF]

				R. A. Bank and V. W.M. van Hinsbergh Lysyl Oxidase: New Looks on LOX Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1365 - 1366. [Full Text] [PDF]